| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/31/2011 | US7951808 Imidazole compounds |
| 05/31/2011 | US7951802 Use of 7-azaindoles in the inhibition of c-Jun N-terminal kinase |
| 05/31/2011 | US7951801 Beta-carbolines useful for treating inflammatory disease |
| 05/31/2011 | CA2649775C Pyridine[3,4-b]pyrazinones |
| 05/31/2011 | CA2501734C Novel bicyclic inhibitors of hormone sensitive lipase |
| 05/31/2011 | CA2483241C Novel diazabicyclononene derivatives |
| 05/31/2011 | CA2475764C New inhibitors of histone deacetylase |
| 05/31/2011 | CA2443488C Mercaptoacetylamide derivatives, a process for their preparation and their use |
| 05/31/2011 | CA2429629C Ligand and complex for catalytically bleaching a substrate |
| 05/31/2011 | CA2353822C Camptothecin analogs and methods of preparation thereof |
| 05/31/2011 | CA2319080C Multivalent antibacterial agents |
| 05/26/2011 | WO2011062885A1 Fused bicyclic pyrimidine derivatives and methods of use thereof |
| 05/26/2011 | WO2011062766A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| 05/26/2011 | WO2011062253A1 Novel fused pyrimidine derivative |
| 05/26/2011 | WO2011061458A1 Pyridine-pyridinone derivatives, preparation and therapeutic use thereof |
| 05/26/2011 | WO2011061318A1 Heterocylic compounds as antagonists of the orexin receptors |
| 05/26/2011 | WO2011061214A1 Novel heterocyclic acrylamides and their use as pharmaceuticals |
| 05/26/2011 | WO2011060867A1 Nitrogen-containing condensed heterocyclic compounds for oleds |
| 05/26/2011 | WO2011000566A3 Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections |
| 05/26/2011 | US20110124866 Process for preparation of tadalafil |
| 05/26/2011 | US20110124863 Process to prepare paliperidone and intermediates thereof |
| 05/26/2011 | US20110124862 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 05/26/2011 | US20110124858 Nitrogen-containing heterocyclic compound and pest control agent |
| 05/26/2011 | US20110124693 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseases |
| 05/26/2011 | US20110124674 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 05/26/2011 | US20110124643 Pyridinopyridinone derivatives, preparation thereof and therapeutic use thereof |
| 05/26/2011 | US20110124642 Potassium channel modulators |
| 05/26/2011 | US20110124638 Pyrido-, Pyrazo- and Pyrimido-Pyrimidine Derivatives as mTOR Inhibitors |
| 05/26/2011 | US20110124637 Benzimidazoles and related analogs as sirtuin modulators |
| 05/26/2011 | US20110124636 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 05/26/2011 | US20110124633 Heterocyclic Compounds, Methods of Making Them and Their Use in Therapy |
| 05/26/2011 | US20110124628 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 05/26/2011 | US20110124627 Modulators of toll-like receptors |
| 05/26/2011 | US20110124624 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseases |
| 05/26/2011 | US20110124622 Isoindolones derivatives as mek kinase inhibitors and methods of use |
| 05/26/2011 | US20110124613 Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma |
| 05/26/2011 | US20110123586 Inhibition of quorum sensing-mediated processes in bacteria |
| 05/26/2011 | US20110123493 2,4,6-TRISUBSTITUTED PYRIDO(3,2-d) PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS |
| 05/26/2011 | CA2781935A1 Pyridine-pyridinone derivatives, preparation and therapeutic use thereof |
| 05/26/2011 | CA2781287A1 Compounds and methods for kinase modulation, and indications therefor |
| 05/26/2011 | CA2780287A1 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| 05/26/2011 | CA2776849A1 Novel heterocyclic acrylamides and their use as pharmaceuticals |
| 05/25/2011 | EP2325263A1 Modified carbocyanine dyes and their conjugates |
| 05/25/2011 | EP2325184A1 Azaindoles useful as inhibitors of protein kinases |
| 05/25/2011 | EP2325175A1 2,4-diaminopyrimidine compound |
| 05/25/2011 | EP2325174A1 Sigma receptor inhibitors |
| 05/25/2011 | EP2324029A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 05/25/2011 | EP2324024A1 Diazacarbazoles and methods of use |
| 05/25/2011 | EP2324023A1 Vigor enhancement via administration of pyrimidine derivatives |
| 05/25/2011 | EP2324022A1 Substituted naphthyridines and use thereof as medicines |
| 05/25/2011 | EP2324021A1 Diazaindole derivatives and their use in the inhibition of c-jun n-terminal kinase |
| 05/25/2011 | EP2324020A2 Piperidine derivatives as jak3 inhibitors |
| 05/25/2011 | EP2324009A1 Process for preparing certain cinnamide compounds |
| 05/25/2011 | EP2323988A1 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 05/25/2011 | EP2323987A1 N-myristoyl transferase inhibitors |
| 05/25/2011 | EP2323986A2 Hetoerocyclyl carbonic acid amides as antiproliferative agents, pdkl inhibitors |
| 05/25/2011 | EP2323659A1 Compounds useful as inhibitors of protein kinases |
| 05/25/2011 | EP2323656A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist |
| 05/25/2011 | EP2323655A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient |
| 05/25/2011 | EP2212297B1 Inhibitors of protein kinases |
| 05/25/2011 | EP2125748B1 Acylaminopyrazoles as fgfr inhibitors |
| 05/25/2011 | EP1833827B1 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine |
| 05/25/2011 | EP1317454B1 Caspase inhibitors and uses thereof |
| 05/25/2011 | CN1771231B Calcium receptor modulating compound and use thereof |
| 05/25/2011 | CN102076687A Substituted quinazolines as blood platelet lowering agents |
| 05/25/2011 | CN102076686A Diketopiperidine derivatives as HIV attachment inhibitors |
| 05/25/2011 | CN102076685A Substituted quinazolines |
| 05/25/2011 | CN102076684A Substituted pyrimidin-4-one derivatives |
| 05/25/2011 | CN102076683A Substituted pyrimido [2, 1-a] isoquinolin-4-one derivatives |
| 05/25/2011 | CN102076341A Substituted pyrimidone derivatives |
| 05/25/2011 | CN102070771A Perylene diimide photoelectric functional materials and preparation method thereof |
| 05/25/2011 | CN102070658A Dimer salt of steroid alkaloid and preparation and application thereof |
| 05/25/2011 | CN102070634A Method for synthesizing 1,7-diazaspiro[4.5]decane with protective group |
| 05/25/2011 | CN102070633A Method for synthesizing 1,8-diazaspiro[4.5]decane with protective group |
| 05/25/2011 | CN102070632A Pyridoimidazole derivatives and application thereof in organic light-emitting devices (OLEDs) |
| 05/25/2011 | CN102070527A Method for extracting high-purity huperzine A and huperzine B from medicinal plant phlegmariurus crutomerianus |
| 05/25/2011 | CN102068430A 1,6-disubstituted-beta-carboline cyclin-dependent kinase 2/Raf kinase dual inhibitor and application thereof |
| 05/25/2011 | CN101585837B Method for separating matrine and oxymatrine from total matrines |
| 05/25/2011 | CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 05/25/2011 | CN101402636B Propellane compounds, preparation method and application thereof |
| 05/25/2011 | CN101273046B Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 05/25/2011 | CN101233140B Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 05/25/2011 | CN101160308B Pharmacetically acceptable salt with decoquinate ketone compound with improved medicine performance |
| 05/25/2011 | CN101133055B MELEIMId derivative for treating cancer, compositions and methods |
| 05/24/2011 | US7947837 Organic semiconductor materials and methods of preparing and use thereof |
| 05/24/2011 | US7947711 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/24/2011 | US7947709 Non-nucleoside reverse transcriptase inhibitors |
| 05/24/2011 | US7947706 Substituted pyrrolopyridines, compositions containing them, manufacturing process therefor and use thereof |
| 05/24/2011 | US7947705 7-azaindoles and the use thereof as therapeutic agents |
| 05/24/2011 | US7947703 Phenanthridinium derivatives as DNA binding agents |
| 05/24/2011 | US7947700 Carboxylic acid amides, the preparation thereof and their use as medicaments |
| 05/24/2011 | US7947690 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example |
| 05/24/2011 | US7947686 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors |
| 05/24/2011 | US7947684 anticoagulants; immunomoderators; antiinflammatory agents |
| 05/24/2011 | US7947679 Fungicides |
| 05/24/2011 | US7947662 Folates, compositions and uses thereof |
| 05/24/2011 | CA2628729C Use of pyrroloquinoline compounds to kill clinically latent microorganisms |
| 05/24/2011 | CA2537066C Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| 05/24/2011 | CA2508194C Use of ibudilast as a phosphodiesterase 10a inhibitor |
| 05/24/2011 | CA2490888C Diaminopyrimidinecarboxamide derivative |